Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Why Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?
04:32pm, Friday, 02'nd Dec 2022 Zacks Investment Research
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
11 Black Friday Dividend Aristocrat Deals
12:02pm, Friday, 18'th Nov 2022 Seeking Alpha
Black Friday is a time to gorge on the world's best blue-chip bargains, not just left-over turkey. Read more here.
3 Stocks With Dividends of 3% or More to Buy on the Dip
02:30pm, Monday, 14'th Nov 2022 The Motley Fool
Three underpriced healthcare stocks provide an opportunity.
3 Stocks With Dividends of 3% or More to Buy on the Dip
09:30am, Monday, 14'th Nov 2022
Three underpriced healthcare stocks provide an opportunity.
Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day
01:35pm, Friday, 11'th Nov 2022 Zacks Investment Research
Douglas Dynamics and Fresenius Medical have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Fresenius Medical (FMS)
12:00pm, Friday, 11'th Nov 2022 Zacks Investment Research
Profit estimates are moving in the wrong direction.
Bear of the Day: Fresenius Medical (FMS)
08:17am, Friday, 11'th Nov 2022
Profit estimates are moving in the wrong direction.
Fresenius Medical's (FMS) Q3 Earnings and Revenues Top
11:21am, Wednesday, 02'nd Nov 2022
Fresenius Medical's (FMS) third-quarter revenues benefit from strong performance across all the geographic regions and segments. However, rising costs hurt margins.
Fresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Call Transcript
02:31pm, Monday, 31'st Oct 2022
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS ) Q3 2022 Earnings Conference Call October 31, 2022 10:30 AM ET Company Participants Dominik Heger - Head of Investor Relations Carla Kriwet - Chief Exec
Fresenius Medical cuts outlook on slower recovery, rising costs
01:10pm, Sunday, 30'th Oct 2022
Kidney dialysis provider Fresenius Medical Care (FMC) on Sunday revised down its forecast for 2022, expecting net income to decline this year, dragged down by rising labour costs and a slower than exp
Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)
06:23am, Thursday, 27'th Oct 2022 Seeking Alpha
Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. See how one can take advantage of FMS stock now.
Fresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)
02:23am, Thursday, 27'th Oct 2022
Fresenius Medical Care has been a long-term laggard in its industry, losing over 70% in the past 5 years. The stock has seemingly bottomed and began to retrace on massive buy-side volume while breakin
Fresenius Medical (FMS) Robust Product Portfolio Drives Growth
04:07pm, Thursday, 25'th Aug 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius Medical (FMS) Robust Product Portfolio Drives Growth
01:33pm, Thursday, 25'th Aug 2022
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
3 Dangerous Dividend Aristocrats To Avoid And 6 High-Yield Aristocrats To Buy Instead
11:00am, Saturday, 20'th Aug 2022 Seeking Alpha
EFAD, EUDV, and EMDV are three aristocratic ETFs that have delivered terrible inflation-adjusted returns. Check out our 6 high-yield aristocrats here.
